Skip to main content

Pairings: May 4, 2011

Premium

Life Technologies has named Ora Hirsch Pescovitz to serve on its board of directors. Pescovitz, who will replace W. Ann Reynolds, is executive VP for medical affairs and Health Systems CEO at the University of Michigan. She formerly was associate dean for research affairs at Indiana University School of Medicine and president and CEO of Riley Hospital for Children.


Illumina CFO Christian Henry said during a quarterly earnings call that the company has appointed Kevin Williams to be its new senior director of investor relations, a position he will take over incrementally over the coming quarter from Peter Fromen. Fromen will move into a new position at Illumina as senior director of applications marketing.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.